Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.66
Delayed Data
As of 3:59pm ET
 -0.04 / -1.48%
Today’s Change
2.30
Today|||52-Week Range
5.30
-45.04%
Year-to-Date
Momenta Pharmaceuticals (MNTA) Jumps: Stock Up 11.3%
Aug 25 / Zacks.com - Paid Partner Content
Intercept (ICPT) Ocaliva Phase III POISE Data Published
Aug 18 / Zacks.com - Paid Partner Content
Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone
Aug 25 / Zacks.com - Paid Partner Content
Portola (PTLA) Stock Down on CRL for AndexXa BLA in U.S.
Aug 18 / Zacks.com - Paid Partner Content
Clovis (CLVS) Stock Up on FDA Priority Review for Rucaparib
Aug 24 / Zacks.com - Paid Partner Content
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Aug 17 / Zacks.com - Paid Partner Content
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content
Radius (RDUS) Osteoporosis Drug Positive in Phase III Study
Aug 17 / Zacks.com - Paid Partner Content
Regeneron Stock Up on BARDA Deal for MERS Antibodies
Aug 23 / Zacks.com - Paid Partner Content
Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 7.9%
Aug 17 / Zacks.com - Paid Partner Content
Alder Biopharmaceuticals (ALDR) Jumps: Stock Rises 9.6%
Aug 23 / Zacks.com - Paid Partner Content
J&J's (JNJ) Depression Treatment Esketamine Gets BTD
Aug 17 / Zacks.com - Paid Partner Content
Sanofi Diabetes Combination Drug FDA Action Date Extended
Aug 22 / Zacks.com - Paid Partner Content
Repros Presents 6-Month Interim Data on Enclomiphene
Aug 16 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval
Aug 22 / Zacks.com - Paid Partner Content
UCB Epilepsy Drug Vimpat's Patent Validated by U.S. Court
Aug 16 / Zacks.com - Paid Partner Content
Horizon (HZNP) Rayos Receives USPTO Notice of Allowance
Aug 19 / Zacks.com - Paid Partner Content
Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down
Aug 16 / Zacks.com - Paid Partner Content
Aclaris (ACRS) Common Warts Candidate Positive in Phase II
Aug 19 / Zacks.com - Paid Partner Content
Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5%
Aug 16 / Zacks.com - Paid Partner Content